TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event

Momentum & Trend

RS New Highs

132 Hits · last calculated September 18, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 100 hits from US

Methodology & criteria

Relative strength rating ≥ 90 and no more than 8% below the 52-week high — leading stocks at or near new highs.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(16)
52-Week High / Low
The highest or lowest price of the last 52 weeks (one trading year). "Within 10% of the 52-week high" means: the stock is trading near its yearly high - a sign of strength, since weakness looks different.
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Relative Strength (RS Rating)
How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

RS New Highs
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
CLYM Climb Bio Inc 11/05 +142 % ⚠ Wildest 10% 93 % Stage 2 D 34 3 of 9 0.8 $ Biotechnology Healthcare 14.10 $ +207.5 % +175.5 % +563.2 % −5.9 % +95.5 % 99 42 7.3 % 8.2 % 0.10 0.0 5.8 0.6 0.0 % -30.9 % -18.5 % 0.00 2 0.0 % 0.0 % 35.4 66.5 % 17.9 % 5.0 (2)
TTMI TTM Technologies Inc 07/29 +498 % 81 % Stage 2 B 66 6 of 9 11.9 $ Electronic Components Technology 114.80 $ +208.9 % +157.3 % +134.1 % −5.9 % +89.3 % 98 50 7.5 % 8.3 % 2.15 93.8 5.6 3.5 9.8 0.36 30.2 8.6 % 21.2 % 7.0 % 11.4 % 5.3 % 0.90 46.2 % +19.0 % 6 0.0 % 0.0 % 7.0 96.0 % 4.4 % 4.8 (4)
UCTT Ultra Clean Holdings Inc 07/27 +70 % ⚠ Wildest 10% 88 % Stage 2 C 50 2 of 9 3.3 $ Semiconductor Equipment & Materials Uses AI Technology 67.50 $ +340.7 % +399.2 % +160.7 % −3.5 % +103.0 % 98 17 8.9 % 8.7 % 1.88 10.5 1.5 4.9 0.30 24.9 2.1 % 15.8 % -1.1 % -22.5 % 2.1 % 1.52 33.9 % -2.1 % 5 0.0 % 0.0 % 6.3 102.9 % 10.7 % 4.8 (4)
LQDA Liquidia Technologies Inc 08/11 +241 % 64 % Stage 2 A 79 7 of 9 6.1 $ Drug Manufacturers - Specialty & Generic Neutral Healthcare 68.40 $ +114.7 % +109.9 % +173.6 % −1.7 % +57.5 % 98 42 6.2 % 6.4 % 0.54 417.7 10.3 13.5 58.2 40.3 32.5 46.3 % 92.5 % 30.7 % 28.2 % 27.0 % 1.70 27.0 % +1,031.2 % 6 0.0 % 0.0 % 2.9 70.2 % 16.4 % 4.3 (10)
ORKA Oruka Therapeutics, Inc. 08/10 +78 % 73 % Stage 2 D 37 1 of 9 6.0 $ Biotechnology Healthcare 97.70 $ +175.2 % +188.0 % +502.9 % −4.8 % +58.6 % 98 42 7.5 % 6.8 % -0.21 0.0 12.5 0.0 0.0 % 0.0 % -27.3 % -13.0 % 0.00 96.5 % +1,105.3 % 2 0.0 % 0.0 % 34.0 89.1 % 17.1 % 4.9 (8)
DFTX Definium Therapeutics, Inc. 07/30 +332 % 74 % Stage 2 D 26 1 of 9 5.1 $ Biotechnology Neutral Healthcare 38.70 $ +170.2 % +246.6 % +304.2 % −4.7 % +67.4 % 98 50 14.0 % 8.8 % 2.24 0.0 19.3 0.0 0.0 % 0.0 % -94.7 % -20.6 % 69.5 % 0.0 % 0.0 % 1.4 65.6 % 7.4 %
ICHR Ichor Holdings Ltd 11/02 +53 % ⚠ Wildest 10% 99 % Stage 2 B 62 4 of 9 1.9 $ Semiconductor Equipment & Materials Technology 53.00 $ +400.3 % +460.1 % +221.3 % −6.5 % +80.9 % 98 28 9.2 % 8.9 % 1.81 15.1 1.8 0.22 288.9 1.1 % 12.7 % -4.0 % -7.4 % 0.4 % 68.7 % +11.6 % 2 0.0 % 0.0 % 7.5 95.3 % 7.8 % 4.4 (7)
AIP Arteris Inc 08/04 +177 % 83 % Stage 2 C 45 3 of 9 1.1 $ Semiconductors Sells AI Technology 22.40 $ +165.9 % +197.1 % +142.4 % −3.8 % +83.0 % 98 42 7.1 % 7.5 % 1.91 144.9 12.5 363.0 158.1 -7.7 -38.0 % 87.6 % -46.7 % -1,369.6 % -14.2 % 2.11 1.8 % +22.3 % 6 0.0 % 0.0 % -3.7 61.1 % 6.3 % 4.5 (4)
SLS Sellas Life Sciences Group Inc 08/11 +148 % ⚠ Wildest 10% 104 % Stage 2 B 58 3 of 9 2.3 $ Biotechnology Uses AI Healthcare 11.50 $ +140.6 % +444.0 % +582.3 % −4.8 % +177.8 % 98 50 12.4 % 11.1 % 2.53 0.0 -1.7 0.0 % 0.0 % -43.6 % -23.3 % 94.1 % -100.0 % 1 0.0 % 0.0 % 16.0 27.6 % 28.8 % 4.7 (3)
ALOT AstroNova Inc +30 % 68 % Stage 2 C 51 9 of 9 0.2 $ Computer Hardware Neutral Technology 29.00 $ +228.3 % +249.6 % +178.5 % −0.8 % -10.3 % 98 81 8.8 % 6.2 % 0.86 14.0 1.5 22.6 39.5 33.8 % -0.9 % -1.8 % 2.6 % -0.5 % 3 0.0 % 0.0 % 7.3 44.9 % 0.5 %
RVMD Revolution Medicines Inc 08/05 +188 % 61 % Stage 2 D 31 1 of 9 40.9 $ Biotechnology Healthcare 196.90 $ +112.8 % +137.2 % +338.3 % −3.4 % +28.2 % 97 42 4.8 % 4.4 % 1.41 0.0 27.8 -9.7 0.0 % -174,708.6 % 0.0 % -76.7 % -30.1 % 0.29 66.6 % -100.0 % 2 0.0 % 0.0 % 1.4 95.7 % 4.8 % 4.7 (12)
FORM FormFactor Inc 07/29 +126 % 85 % Stage 2 A 79 8 of 9 9.5 $ Semiconductor Equipment & Materials Uses AI Technology 111.50 $ +156.0 % +147.9 % +251.1 % −6.5 % +24.3 % 97 91 9.4 % 8.6 % 1.24 110.5 28.3 10.6 7.1 70.0 1.39 42.9 17.7 % 46.2 % 12.8 % 6.8 % 7.4 % 0.04 84.3 % +2.8 % 5 0.0 % 0.0 % 12.3 98.8 % 5.4 % 3.7 (10)
KLIC Kulicke and Soffa Industries Inc 08/05 +47 % 57 % Stage 2 A 77 6 of 9 4.3 $ Semiconductor Equipment & Materials Neutral Technology 81.90 $ +180.3 % +179.3 % +101.7 % −1.4 % +30.2 % 97 6 7.6 % 6.8 % 1.62 75.2 11.7 4.5 5.0 107.4 2.38 22.7 15.9 % 52.6 % 12.2 % 6.4 % 9.0 % 0.05 72.3 % -7.4 % 4 1.0 % 31.5 % 13.9 93.1 % 4.9 % 4.0 (5)
ACMR Acm Research Inc 08/05 +247 % ⚠ Wildest 10% 87 % Stage 2 B 66 3 of 9 4.6 $ Semiconductor Equipment & Materials Neutral Technology 67.80 $ +151.3 % +196.5 % +100.7 % −4.1 % +73.7 % 97 24 10.7 % 10.4 % 1.95 48.7 23.9 4.5 2.9 12.7 15.6 % 43.8 % 14.5 % 7.6 % 3.2 % 0.21 51.6 % +15.2 % 6 0.0 % 0.0 % 9.7 74.2 % 7.3 % 4.3 (9)
COHU Cohu Inc 07/30 +21 % 69 % Stage 2 B 66 6 of 9 2.6 $ Semiconductor Equipment & Materials Sells AI Technology 55.00 $ +176.6 % +189.3 % +150.7 % −5.0 % +28.9 % 97 5 7.9 % 7.4 % 1.59 26.1 5.0 3.3 74.4 1.15 102.9 -8.3 % 44.0 % -7.4 % -7.0 % -1.8 % 0.43 62.3 % +12.7 % 4 0.0 % 0.0 % 8.6 109.5 % 22.2 % 4.6 (5)
RLAY Relay Therapeutics Inc 08/06 +16 % 67 % Stage 2 D 29 3 of 9 4.2 $ Biotechnology Healthcare 19.20 $ +106.1 % +128.2 % +369.2 % −5.9 % +41.0 % 97 42 6.4 % 8.1 % 1.70 0.0 399.3 -0.8 -2,619.7 % -2,497.6 % 0.0 % -40.0 % -22.9 % 91.8 % +53.4 % 5 0.0 % 0.0 % 8.5 87.0 % 23.1 % 4.3 (13)
MBX MBX Biosciences, Inc. 08/06 ⚠ Wildest 10% 105 % Stage 2 D 34 3 of 9 2.9 $ Biotechnology Neutral Healthcare 63.90 $ +47.1 % +67.7 % +542.8 % −4.1 % +38.3 % 97 42 8.5 % 7.7 % 0.04 0.0 7.0 0.0 0.0 % 0.0 % -25.7 % -22.1 % 0.00 96.7 % 2 0.0 % 0.0 % 37.2 111.5 % 12.1 % 4.6 (5)
RFIL RF Industries Ltd +133 % ⚠ Wildest 10% 89 % Stage 2 B 72 7 of 9 0.1 $ Electrical Equipment & Parts Neutral Industrials 7.90 $ +265.4 % +254.2 % +12.0 % −6.1 % +107.3 % 97 61 12.2 % 9.9 % 1.30 60.5 9.9 1.0 2.3 27.5 18.3 35.1 % 2.8 % 3.9 % 4.3 % 0.65 +24.3 % 5 0.0 % 0.0 % 6.5 44.1 % 7.8 % 5.0 (1)
FLEX Flex Ltd 07/23 +225 % 66 % Stage 2 B 64 6 of 9 41.0 $ Electronic Components Technology 109.00 $ +151.3 % +151.1 % +93.1 % −3.3 % +48.7 % 96 63 7.5 % 6.7 % 1.65 41.3 23.3 1.4 6.8 49.6 0.94 20.9 5.7 % 9.5 % 3.3 % 17.3 % 4.4 % 1.14 23.3 % +8.1 % 5 0.0 % 0.0 % 5.6 101.2 % 3.0 % 4.5 (11)
MKSI MKS Instruments Inc 08/05 +98 % 63 % Stage 2 B 72 6 of 9 17.5 $ Scientific & Technical Instruments Uses AI Technology 240.20 $ +144.0 % +155.0 % +99.6 % −2.7 % +77.5 % 96 78 6.7 % 6.4 % 1.97 47.7 10.4 4.0 5.5 38.6 1.32 19.3 16.1 % 46.9 % 10.1 % 12.7 % 5.0 % 17.45 32.2 % +9.6 % 4 0.4 % 9.7 % 4.7 104.9 % 10.5 % 4.5 (12)
ARWR Arrowhead Pharmaceuticals Inc 08/06 +42 % 61 % Stage 2 D 36 3 of 9 9.5 $ Biotechnology Healthcare 67.70 $ +20.3 % +14.8 % +132.5 % −6.2 % +67.2 % 96 58 4.9 % 5.1 % 1.28 111.1 14.2 15.6 27.9 -191.6 % 100.0 % -47.8 % -42.4 % -8.1 % 2.24 27.1 % +23,258.2 % 7 0.0 % 0.0 % 5.1 88.6 % 9.3 % 4.4 (13)
AGX Argan Inc +629 % 76 % Stage 2 A 77 5 of 9 5.8 $ Engineering & Construction Uses AI Industrials 383.00 $ +135.6 % +141.6 % +60.7 % −4.8 % +49.6 % 96 86 7.0 % 7.0 % 0.57 33.8 16.6 4.9 11.2 10.6 23.2 15.6 % 20.7 % 15.1 % 38.5 % 10.0 % 36.8 % +8.1 % 8 0.7 % 15.8 % 8.1 108.9 % 7.8 % 4.0 (2)
GTX Garrett Motion Inc 07/23 +124 % 49 % Stage 2 B 62 8 of 9 4.9 $ Auto Parts Uses AI Consumer Cyclical 26.30 $ +94.9 % +102.6 % +102.7 % −0.6 % +41.3 % 96 80 3.6 % 4.0 % 0.80 15.3 11.7 1.3 0.0 13.0 9.2 14.1 % 20.8 % 9.5 % 0.0 % 14.1 % -1.88 -32.9 % +3.1 % 2 1.3 % 17.3 % 2.6 96.1 % 2.6 % 4.0 (1)
APGE Apogee Therapeutics, Inc. 08/10 63 % Stage 2 D 37 4 of 9 10.1 $ Biotechnology Healthcare 135.10 $ +76.0 % +69.8 % +254.0 % −0.4 % -0.4 % 96 42 6.7 % 6.5 % 0.33 0.0 8.1 0.0 0.0 % 0.0 % -28.5 % -20.3 % 0.01 97.1 % 3 0.0 % 0.0 % 40.3 131.6 % 7.3 % 5.0 (9)
TWST Twist Bioscience Corp 08/03 +131 % 73 % Stage 2 D 41 4 of 9 9.7 $ Diagnostics & Research Threatened Healthcare 155.60 $ +168.0 % +192.9 % +476.8 % −1.8 % -31.7 % 96 42 7.7 % 7.8 % 2.22 0.0 22.4 20.0 -35.3 -34.9 % 52.0 % -31.7 % -18.2 % -13.1 % 0.21 67.3 % +20.3 % 5 0.0 % 0.0 % -0.1 123.8 % 23.0 % 4.2 (12)
TVTX Travere Therapeutics Inc 08/05 +82 % 62 % Stage 2 B 56 5 of 9 5.9 $ Biotechnology Uses AI Healthcare 64.70 $ +46.4 % +44.7 % +173.7 % −1.8 % +14.7 % 96 42 3.6 % 4.6 % 1.06 41.7 10.0 59.2 83.6 1,042.1 -29.0 % 59.2 % -7.4 % -69.4 % -3.7 % 3.35 17.8 % +110.5 % 6 0.0 % 0.0 % -2.7 113.4 % 16.6 % 4.6 (15)
DNTH Dianthus Therapeutics Inc. 08/06 +247 % 60 % Stage 2 D 39 4 of 9 5.5 $ Biotechnology Healthcare 101.10 $ +112.4 % +121.7 % +160.1 % −5.1 % +31.1 % 96 50 5.9 % 6.6 % 0.06 0.0 -7.3 -10,050.3 % 100.0 % 0.0 % -22.7 % -17.7 % 96.4 % -67.4 % 4 0.0 % 0.0 % 35.6 120.4 % 17.3 % 4.8 (12)
NWPX Northwest Pipe Company 08/06 +127 % 40 % Stage 2 B 71 8 of 9 1.0 $ Steel Basic Materials 103.00 $ +121.8 % +130.9 % +98.8 % −3.6 % +7.8 % 96 90 4.6 % 4.4 % 1.10 24.1 19.8 1.8 2.4 12.7 1.80 12.4 9.2 % 20.9 % 8.5 % 10.7 % 6.5 % 0.25 63.7 % +6.8 % 5 0.0 % 0.0 % 9.1 87.9 % 8.3 % 4.0 (2)
DWSN Dawson Geophysical Company 08/11 +12 % ⚠ Wildest 10% 127 % Stage 2 B 60 5 of 9 0.1 $ Oil & Gas Equipment & Services Energy 3.30 $ +192.9 % +232.9 % +103.1 % −2.0 % +25.0 % 96 96 9.5 % 10.2 % -0.04 3.8 1.0 12.17 9.3 22.3 % 3.5 % 22.7 % 6.6 % +2.0 % 2 0.0 % 0.0 % -2.2 86.1 % 4.3 %
MTSI MACOM Technology Solutions Holdings, Inc. 08/06 +176 % 62 % Stage 2 B 71 8 of 9 21.4 $ Semiconductors Sells AI Technology 263.10 $ +117.3 % +111.9 % +99.6 % −6.9 % +57.0 % 95 75 6.2 % 6.4 % 1.71 103.8 28.0 18.4 13.2 113.1 2.05 50.4 17.6 % 56.5 % 20.7 % 13.5 % 6.4 % 0.35 70.4 % +32.6 % 7 0.0 % 0.0 % 9.4 99.6 % 4.4 % 4.3 (16)
ONTO Onto Innovation Inc 08/06 +67 % 72 % Stage 2 C 51 2 of 9 13.7 $ Semiconductor Equipment & Materials Technology 250.00 $ +100.1 % +117.1 % +115.5 % −2.5 % +58.6 % 95 15 8.1 % 7.3 % 1.58 109.7 21.2 12.2 5.5 54.3 0.71 49.6 16.8 % 55.5 % 11.8 % 5.3 % 4.8 % 89.0 % +1.8 % 5 0.0 % 0.0 % 16.2 100.4 % 6.4 % 4.1 (9)
GFS Globalfoundries Inc 08/04 +15 % 60 % Stage 2 B 58 5 of 9 25.4 $ Semiconductors Technology 45.80 $ +138.8 % +126.9 % +42.6 % −7.0 % +76.7 % 95 14 6.4 % 7.2 % 1.77 27.9 17.1 3.7 2.1 23.6 0.65 10.5 11.0 % 27.1 % 10.3 % 6.8 % 3.0 % 0.15 69.2 % +0.6 % 4 1.1 % 14.2 % 5.1 103.1 % 14.9 % 3.8 (20)
SNEX Stonex Group Inc 08/04 +151 % 47 % Stage 2 B 55 6 of 9 7.9 $ Capital Markets Neutral Financial Services 66.10 $ +117.5 % +77.2 % +57.9 % −3.3 % +13.5 % 95 87 6.0 % 4.9 % 0.64 17.7 9.8 0.1 2.9 1.5 10.6 0.5 % 1.7 % 0.3 % 20.2 % 1.2 % 7.16 5.0 % +32.5 % 2 0.0 % 0.0 % 5.5 85.9 % 4.7 % 5.0 (2)
MYRG MYR Group Inc 07/29 +84 % 50 % Stage 2 B 68 9 of 9 4.5 $ Engineering & Construction Neutral Industrials 276.80 $ +114.2 % +120.8 % +56.3 % −0.9 % +48.8 % 95 86 5.2 % 5.4 % 1.31 30.3 20.0 1.1 6.1 23.0 3.41 14.1 6.4 % 12.5 % 4.1 % 22.7 % 8.5 % 0.11 42.0 % +8.8 % 5 0.0 % 0.0 % 6.9 104.4 % 5.3 % 4.6 (5)
MTRN Materion Corporation 11/04 +50 % 58 % Stage 2 B 61 5 of 9 5.5 $ Other Industrial Metals & Mining Neutral Basic Materials 250.50 $ +113.8 % +126.6 % +114.2 % −1.5 % +21.3 % 95 57 5.2 % 4.9 % 1.08 67.0 27.9 2.6 5.3 112.3 1.28 27.4 5.7 % 16.0 % 4.3 % 8.3 % 4.6 % 0.83 51.0 % +6.1 % 3 0.2 % 9.3 % 8.4 97.2 % 4.1 % 4.0 (3)
SPHR Sphere Entertainment Co. 08/06 +158 % 51 % Stage 2 C 50 9 of 9 4.2 $ Entertainment Uses AI Communication Services 144.90 $ +66.4 % +83.4 % +135.9 % −0.4 % +22.1 % 95 50 4.7 % 4.8 % 1.61 63.3 28.4 3.1 3.0 11.3 28.8 2.7 % 54.7 % -5.7 % 5.5 % -1.3 % 0.42 53.2 % +0.0 % 5 0.0 % 0.0 % 4.9 130.0 % 31.2 % 3.8 (10)
TXG 10X Genomics Inc 08/06 -14 % 71 % Stage 2 C 46 6 of 9 10.1 $ Health Information Services Uses AI Healthcare 77.00 $ +95.4 % +122.6 % +498.5 % −3.1 % -32.3 % 95 42 8.2 % 7.9 % 2.08 1,250.0 16.4 12.2 83.2 148.5 -11.3 % 70.1 % -12.2 % -3.0 % -5.1 % 0.10 80.2 % +5.3 % 4 0.0 % 0.0 % 6.5 113.8 % 18.2 % 3.8 (16)
CLOV Clover Health Investments Corp 08/04 +157 % 67 % Stage 2 B 60 6 of 9 2.4 $ Healthcare Plans Uses AI Healthcare 4.50 $ +115.3 % +109.9 % +47.9 % −2.6 % +14.8 % 95 42 5.8 % 6.8 % 2.48 37.7 1.0 32.0 -0.6 3.7 % 18.5 % -0.7 % -16.9 % -1.8 % 48.7 % +40.3 % 5 0.0 % 0.0 % -5.8 30.0 % 5.6 % 4.0 (4)
ELVN Enliven Therapeutics Inc. 08/12 +44 % 74 % Stage 2 D 32 4 of 9 3.4 $ Biotechnology Healthcare 50.20 $ +215.6 % +203.9 % +164.1 % −2.8 % +47.2 % 95 42 6.6 % 6.9 % 0.25 0.0 8.1 -6.3 0.0 % 0.0 % -26.6 % -11.0 % 0.00 97.5 % 2 0.0 % 0.0 % 47.0 89.7 % 16.9 % 4.9 (8)
AXGN Axogen Inc 08/04 +132 % 54 % Stage 2 C 52 4 of 9 2.4 $ Medical Devices Healthcare 45.30 $ +36.5 % +37.0 % +169.2 % −3.3 % +19.0 % 95 42 5.2 % 4.9 % 1.16 105.3 9.6 9.9 291.8 99.04 4,083.5 -4.6 % 74.6 % -13.4 % -18.0 % -3.2 % 0.08 84.6 % +20.2 % 4 0.0 % 0.0 % 8.5 94.7 % 8.2 % 4.7 (7)
VSTS Vestis Corporation 08/04 56 % Stage 2 C 50 8 of 9 1.8 $ Rental & Leasing Services Industrials 13.80 $ +97.9 % +120.0 % +240.9 % −2.0 % -5.8 % 95 3 3.9 % 4.3 % 1.11 0.0 0.7 11.7 13.6 4.2 % 26.3 % -0.2 % -2.0 % 2.5 % 30.2 % -2.5 % 4 0.0 % 0.0 % 4.9 101.7 % 9.7 % 3.3 (9)
APPS Digital Turbine Inc 08/04 -13 % ⚠ Wildest 10% 93 % Stage 2 B 69 6 of 9 1.4 $ Software - Application Uses AI Technology 11.00 $ +85.2 % +140.0 % +111.2 % −5.9 % +56.1 % 95 17 10.7 % 12.7 % 2.88 285.7 2.3 63.6 0.69 15.6 49.1 % -5.8 % -21.8 % 4.7 % +15.2 % 5 0.0 % 0.0 % 0.9 66.7 % 8.7 % 3.5 (2)
MGRM Monogram Orthopaedics Inc. ⚠ Wildest 10% 91 % Stage 2 C 49 3 of 9 0.2 $ Medical Devices Healthcare 6.00 $ +153.2 % +140.0 % +158.6 % −6.6 % +0.0 % 95 42 2.7 % 2.7 % 0.69 0.0 600.0 -5.1 100.0 % 0.0 % -228.8 % -72.9 % -100.0 % 3 0.0 % 0.0 % -15.5 5.0 % 0.5 % 4.0 (1)
NVCT Nuvectis Pharma Inc 08/04 +1 % 84 % Stage 2 D 29 1 of 9 0.7 $ Biotechnology Healthcare 21.40 $ +132.5 % +270.0 % +245.4 % −0.2 % +51.3 % 95 42 16.4 % 9.8 % -0.26 0.0 -7.4 0.0 % -154.4 % -73.1 % -100.0 % 3 0.0 % 0.0 % -7.1 18.2 % 10.1 % 4.3 (6)
SNX Synnex Corporation +71 % 33 % Stage 2 B 66 5 of 9 21.4 $ Electronics & Computer Distribution Sells AI Technology 264.40 $ +94.2 % +77.4 % +79.9 % −6.4 % +28.4 % 94 86 4.3 % 4.0 % 1.43 17.9 12.3 0.3 2.3 17.1 0.77 11.0 2.7 % 7.0 % 1.6 % 11.7 % 3.3 % 0.23 23.2 % +6.9 % 4 0.7 % 11.2 % 5.1 95.7 % 2.3 % 4.4 (11)
BTSG BrightSpring Health Services, Inc. 08/07 45 % Stage 2 B 73 8 of 9 11.2 $ Health Information Services Uses AI Healthcare 56.60 $ +78.5 % +82.8 % +106.6 % −0.2 % +33.8 % 94 94 3.0 % 3.3 % 1.85 73.3 23.9 0.8 5.6 27.8 22.6 3.4 % 12.4 % 2.6 % 9.2 % 4.9 % -4.87 31.9 % +14.6 % 5 0.0 % 0.0 % 5.5 101.5 % 8.0 % 4.7 (12)
ACLS Axcelis Technologies Inc 08/04 +1 % 68 % Stage 2 C 53 6 of 9 3.2 $ Semiconductor Equipment & Materials Technology 104.60 $ +112.9 % +112.7 % +14.8 % −6.8 % +53.9 % 94 10 7.1 % 7.1 % 1.86 32.0 18.0 3.7 3.0 49.1 1.45 22.3 4.0 % 43.0 % 10.7 % 9.7 % 4.1 % 0.04 76.0 % -17.6 % 4 0.0 % 0.0 % 11.9 110.0 % 7.6 % 3.6 (5)
OSCR Oscar Health Inc 08/05 +84 % 69 % Stage 2 B 64 7 of 9 9.2 $ Healthcare Plans Uses AI Healthcare 32.00 $ +108.3 % +97.3 % +80.0 % −5.6 % -4.1 % 94 87 5.6 % 6.6 % 2.37 588.2 0.6 6.1 2.1 0.0 15.2 % 20.2 % 3.6 % -2.6 % 4.5 % 0.26 17.9 % +27.5 % 4 0.0 % 0.0 % 3.0 67.6 % 6.5 % 3.3 (7)
CECO CECO Environmental Corp. 08/04 +219 % 66 % Stage 2 B 63 5 of 9 2.6 $ Pollution & Treatment Controls Industrials 70.80 $ +61.5 % +44.1 % +44.4 % −6.1 % +54.2 % 94 17 4.7 % 6.4 % 1.51 175.5 25.7 2.9 12.5 1.44 229.5 5.9 % 32.2 % -3.4 % 5.4 % 1.5 % 0.09 30.4 % +38.8 % 7 0.0 % 0.0 % 5.1 54.8 % 3.3 % 4.5 (6)
XMTR Xometry Inc 08/04 +114 % 81 % Stage 2 B 67 5 of 9 5.2 $ Industrial Distribution Industrials 95.30 $ +54.3 % +48.6 % +84.4 % −7.3 % +15.7 % 94 42 4.8 % 5.7 % 1.32 78.7 6.5 16.9 -13.1 -2.5 % 38.8 % -3.8 % -17.5 % -2.2 % 1.21 38.1 % +25.9 % 5 0.0 % 0.0 % 3.0 96.4 % 8.1 % 3.9 (10)
BHE Benchmark Electronics Inc 07/29 +95 % 44 % Stage 2 B 62 8 of 9 2.7 $ Electronic Components Neutral Technology 74.60 $ +113.2 % +113.5 % +92.3 % −1.3 % +15.3 % 94 92 5.0 % 4.8 % 1.27 73.9 14.1 1.0 2.4 21.6 1.33 17.5 3.8 % 10.3 % 1.9 % 3.1 % 3.1 % 0.28 52.3 % +0.1 % 4 0.9 % 27.1 % 8.1 107.4 % 4.4 % 4.0 (3)
NESR National Energy Services Reunited Corp. 08/19 +252 % 55 % Stage 2 B 69 7 of 9 3.3 $ Oil & Gas Equipment & Services Neutral Energy 32.50 $ +60.1 % +89.1 % +208.3 % −2.6 % +33.2 % 94 87 5.7 % 5.1 % 0.40 50.0 0.0 2.0 3.2 14.2 11.8 8.9 % 13.3 % 5.8 % 6.7 % 4.8 % 0.31 51.7 % +1.7 % 7 0.0 % 0.0 % 5.0 85.2 % 5.2 % 4.3 (3)
URGN UroGen Pharma Ltd 08/06 +18 % 65 % Stage 2 B 63 3 of 9 2.1 $ Biotechnology Uses AI Healthcare 44.00 $ +50.1 % +51.8 % +142.8 % −4.7 % +36.4 % 94 42 5.1 % 5.4 % 1.58 36.6 11.2 -2.6 -39.8 % 90.9 % -51.7 % -1,481.3 % -18.1 % -49.0 % +21.5 % 4 0.0 % 0.0 % -8.0 100.6 % 13.0 % 4.4 (8)
MOV Movado Group Inc +25 % 38 % Stage 2 B 66 8 of 9 0.7 $ Luxury Goods Consumer Cyclical 33.40 $ +92.4 % +95.2 % +78.3 % −3.9 % +42.6 % 94 50 3.2 % 4.3 % 0.94 25.3 21.1 1.1 1.6 10.4 0.84 9.5 56.1 % 6.0 % 6.5 % 4.0 % 0.15 +2.7 % 5 4.9 % 81.1 % 11.5 91.4 % 7.6 % 4.0 (1)
MEI Methode Electronics Inc -18 % ⚠ Wildest 10% 94 % Stage 2 D 43 3 of 9 0.5 $ Electronic Components Uses AI Technology 13.50 $ +104.6 % +185.0 % +71.2 % −2.3 % +66.7 % 94 2 13.1 % 9.7 % 1.54 10.2 0.5 0.7 0.78 10.8 19.8 % -3.5 % -9.3 % 0.5 % 0.52 -2.8 % 4 1.4 % 36.4 % 7.2 93.1 % 9.3 % 3.7 (3)
ACRS Aclaris Therapeutics Inc 08/06 -17 % ⚠ Wildest 10% 86 % Stage 2 D 27 5 of 9 0.7 $ Biotechnology Healthcare 5.40 $ +63.5 % +65.1 % +198.3 % −4.7 % +88.6 % 94 42 5.9 % 5.5 % 0.80 0.0 91.1 0.3 -757.7 % 0.0 % -48.4 % -29.0 % -58.2 % 3 0.0 % 0.0 % -9.9 79.7 % 11.7 % 4.3 (6)
AVR Anteris Technologies Global Corp. 08/10 68 % Stage 2 C 46 4 of 9 0.8 $ Medical Instruments & Supplies Healthcare 8.40 $ +106.0 % +80.8 % +50.1 % −6.4 % +82.5 % 94 42 6.4 % 6.9 % 0.73 0.0 373.2 0.0 75.0 % 0.0 % -59.2 % -42.5 % -29.2 % 5 0.0 % 0.0 % 20.7 66.1 % 10.2 % 4.8 (4)
MEC Mayville Engineering Co Inc 08/04 +51 % 55 % Stage 2 C 50 3 of 9 0.4 $ Metal Fabrication Industrials 17.40 $ +82.5 % +96.1 % +23.2 % −3.3 % +115.2 % 94 1 5.2 % 6.5 % 1.26 22.1 0.8 2.0 20.3 10.9 % -2.9 % -6.8 % -1.1 % 0.10 -6.0 % 5 0.0 % 0.0 % 4.6 60.8 % 9.0 % 4.3 (3)
RCUS Arcus Biosciences Inc 08/05 +16 % 62 % Stage 2 D 33 0 of 9 3.2 $ Biotechnology Neutral Healthcare 25.50 $ +18.3 % +34.4 % +112.3 % −3.8 % +52.0 % 93 42 6.2 % 6.0 % 0.81 0.0 27.4 6.3 4.0 -788.2 % -324.8 % 0.0 % -70.0 % -30.4 % 0.22 52.6 % -4.3 % 4 0.0 % 0.0 % 1.0 72.4 % 16.8 % 4.5 (13)
CRS Carpenter Technology Corporation 07/30 +349 % 49 % Stage 2 B 68 8 of 9 20.2 $ Metal Fabrication Neutral Industrials 406.70 $ +83.8 % +81.7 % +71.1 % −1.0 % +52.0 % 93 77 3.8 % 4.1 % 1.26 41.6 23.4 6.5 9.6 45.2 1.59 25.0 22.8 % 30.6 % 17.0 % 24.9 % 11.9 % 0.38 56.2 % +4.3 % 6 0.2 % 7.4 % 10.1 97.9 % 3.1 % 4.7 (9)
GSAT Globalstar, Inc. 08/06 +150 % 59 % Stage 2 D 34 5 of 9 10.6 $ Telecom Services Communication Services 82.50 $ +30.9 % +28.3 % +140.7 % −5.6 % +9.9 % 93 42 1.5 % 1.5 % 1.50 9.2 37.9 30.9 158.3 0.50 117.1 16.3 % 62.3 % -18.5 % -2.5 % 0.4 % 1.54 14.4 % +9.0 % 9 0.0 % 0.0 % 1.0 26.3 % 8.0 % 4.3 (3)
BELFB Bel Fuse B Inc 07/23 +142 % 55 % Stage 2 B 58 5 of 9 2.9 $ Electronic Components Neutral Technology 238.30 $ +70.3 % +79.3 % +65.0 % −0.4 % +43.1 % 93 50 5.4 % 5.5 % 1.39 65.3 26.1 3.9 8.8 39.3 1.74 24.9 13.5 % 39.5 % 7.2 % 14.2 % 6.9 % 0.52 46.1 % +26.3 % 3 0.1 % 3.8 % 8.4 90.5 % 7.4 % 4.8 (5)
KALU Kaiser Aluminum Corporation 07/22 +64 % 52 % Stage 2 B 68 7 of 9 2.6 $ Aluminum Basic Materials 155.10 $ +57.6 % +61.9 % +106.4 % −6.9 % +9.9 % 93 90 4.5 % 4.7 % 1.60 17.3 27.7 0.6 3.0 23.6 1.17 7.2 8.8 % 14.5 % 5.5 % 18.8 % 7.8 % 1.22 31.5 % +11.5 % 3 2.1 % 24.3 % 6.7 100.8 % 6.8 % 3.7 (3)
LION Lionsgate Studios Holding Corp. 08/06 +15 % 47 % Stage 2 C 47 6 of 9 3.3 $ Shell Companies Financial Services 11.30 $ +64.3 % +75.6 % +58.2 % −5.3 % +32.8 % 93 50 5.4 % 4.9 % 23.5 1.2 34.5 5.6 0.0 % 0.0 % 0.0 % 0.0 % -22.4 % -17.6 % 2 0.0 % 0.0 % -1.1 100.5 % 0.3 % 4.0 (9)
EWTX Edgewise Therapeutics Inc 08/06 +137 % 75 % Stage 2 D 25 3 of 9 4.7 $ Biotechnology Healthcare 46.90 $ +56.5 % +49.9 % +237.9 % −5.1 % +10.2 % 93 42 7.6 % 6.7 % 0.33 0.0 10.4 -2.6 0.0 % 0.0 % -38.1 % -25.0 % 0.01 95.1 % 2 0.0 % 0.0 % 23.8 113.9 % 12.1 % 4.3 (10)
TRVI Trevi Therapeutics Inc 08/06 +178 % 58 % Stage 2 D 28 3 of 9 2.2 $ Biotechnology Healthcare 15.20 $ +38.8 % +43.6 % +90.6 % −0.9 % +85.4 % 93 42 6.1 % 5.0 % 1.05 0.0 -4.9 0.0 % 0.0 % -33.6 % -13.8 % 95.8 % 2 0.0 % 0.0 % 25.7 98.3 % 9.4 % 4.9 (8)
ALNT Allient Inc. 08/05 +50 % 59 % Stage 2 B 61 7 of 9 1.7 $ Electronic Components Neutral Technology 99.10 $ +78.9 % +77.1 % +116.6 % −2.3 % +30.2 % 93 50 6.4 % 6.4 % 1.62 75.8 29.4 2.9 6.0 61.1 25.2 7.3 % 33.3 % 5.0 % 8.2 % 5.4 % 0.65 53.0 % +4.6 % 6 0.2 % 5.7 % 8.4 78.8 % 4.3 % 4.0 (3)
PGEN Precigen Inc 08/11 +125 % 78 % Stage 2 B 64 4 of 9 2.8 $ Biotechnology Neutral Healthcare 7.90 $ +28.2 % +41.3 % +106.0 % −2.8 % +83.5 % 93 42 6.5 % 6.9 % 1.02 15.9 32.8 151.9 -3.3 -25.8 % 53.0 % -184.0 % -1,145.4 % -18.1 % 4.86 14.6 % +146.7 % 2 0.0 % 0.0 % -57.6 71.1 % 21.6 % 3.8 (4)
CGEM Cullinan Oncology LLC 08/06 +14 % 75 % Stage 2 C 50 1 of 9 1.3 $ Biotechnology Healthcare 21.40 $ +71.5 % +79.5 % +260.2 % −1.5 % +56.8 % 93 42 8.3 % 8.2 % 0.02 6.7 -1.5 0.0 % -48.2 % -31.4 % -100.0 % 3 0.0 % 0.0 % 10.2 107.8 % 22.4 % 4.9 (9)
CTOS Custom Truck One Source Inc 07/29 +23 % 47 % Stage 2 B 67 7 of 9 2.1 $ Rental & Leasing Services Industrials 9.10 $ +95.3 % +99.5 % +62.7 % −2.1 % +46.5 % 93 21 4.8 % 4.3 % 1.36 31.2 1.0 2.5 29.0 10.5 22.2 % 1.1 % -2.2 % 3.1 % 3.09 +7.9 % 3 0.0 % 0.0 % 3.8 97.0 % 7.4 % 4.0 (6)
CLDT Chatham Lodging Trust REIT 08/05 +22 % 30 % Stage 2 C 46 5 of 9 0.6 $ REIT - Hotel & Motel Real Estate 12.80 $ +100.8 % +98.8 % +93.3 % −2.2 % +8.3 % 93 19 3.5 % 3.0 % 1.10 661.3 238.1 2.1 0.8 8.2 2.28 10.6 49.1 % 4.0 % 1.2 % 1.6 % 0.61 -7.0 % 4 3.1 % 54.2 % 4.1 97.8 % 3.2 % 4.0 (4)
MRVI Maravai Lifesciences Holdings Inc 08/10 -20 % 66 % Stage 2 B 61 5 of 9 2.6 $ Biotechnology Healthcare 7.30 $ +65.2 % +93.6 % +158.7 % −1.6 % +1.6 % 93 19 5.9 % 5.5 % 0.61 370.4 12.7 5.1 1.8 35.7 % -37.1 % -41.0 % -5.7 % 1.28 -28.3 % 2 0.0 % 0.0 % 4.3 88.5 % 8.7 % 3.9 (13)
WEST Westrock Coffee Company 08/06 -6 % 65 % Stage 2 C 50 3 of 9 0.8 $ Packaged Foods Consumer Defensive 7.80 $ +123.1 % +98.3 % +45.7 % −2.4 % +28.2 % 93 50 7.4 % 6.7 % 0.89 0.0 0.6 32.3 12.5 % -4.9 % -24.0 % -0.1 % +39.8 % 3 0.0 % 0.0 % 1.8 49.5 % 13.4 % 5.0 (5)
BELFA Bel Fuse A Inc 07/23 +120 % 59 % Stage 2 B 65 6 of 9 2.5 $ Electronic Components Technology 194.80 $ +66.6 % +73.7 % +59.1 % −3.0 % +60.7 % 93 18 5.9 % 5.9 % 1.39 19.6 3.3 33.8 1.31 22.9 39.5 % 7.2 % 14.2 % 6.9 % +26.3 % 4 0.1 % 3.0 % 8.4 56.2 % 10.5 % 5.0 (2)
CCCC C4 Therapeutics Inc 08/06 -23 % 83 % Stage 2 C 47 4 of 9 0.4 $ Biotechnology Healthcare 3.40 $ +120.9 % +109.1 % +1.0 % −4.3 % +292.2 % 93 42 7.7 % 9.3 % 2.95 0.0 11.0 1.6 -0.4 86.3 % -289.4 % -48.4 % -19.3 % 0.25 +1.0 % 3 0.0 % 0.0 % 0.5 85.1 % 30.6 % 4.0 (8)
FTRE Fortrea Holdings Inc. 08/05 -17 % 73 % Stage 2 C 49 4 of 9 1.8 $ Biotechnology Uses AI Healthcare 20.30 $ -4.6 % -1.0 % +96.7 % −5.1 % +1.2 % 92 13 6.2 % 6.3 % 1.95 12.3 0.7 8.9 0.34 33.4 0.5 % 19.3 % -3.2 % -64.6 % 0.6 % 19.6 % +1.0 % 3 0.0 % 0.0 % 0.8 110.4 % 14.7 % 3.0 (12)
SEI Solaris Energy Infrastructure, Inc 07/22 +327 % 78 % Stage 2 B 69 5 of 9 6.8 $ Oil & Gas Equipment & Services Sells AI Energy 69.20 $ +70.3 % +76.6 % +109.9 % −7.8 % +39.3 % 92 87 7.0 % 7.1 % 1.26 384.6 9.0 0.94 23.5 25.8 % 49.9 % 7.2 % 8.7 % 4.1 % 26.1 % +98.7 % 5 0.8 % 43.2 % 4.1 113.1 % 23.8 % 4.9 (8)
ATI ATI Inc. 07/30 +136 % 42 % Stage 2 B 66 8 of 9 25.6 $ Metal Fabrication Industrials 183.60 $ +73.9 % +69.5 % +138.6 % −2.8 % +37.0 % 92 69 3.3 % 4.1 % 1.01 59.5 29.4 5.4 13.9 43.1 1.20 30.7 16.1 % 23.7 % 10.1 % 22.7 % 8.8 % 1.18 33.8 % +5.2 % 4 0.0 % 0.0 % 7.2 96.9 % 4.1 % 4.5 (11)
GH Guardant Health Inc 07/29 +89 % 57 % Stage 2 B 55 6 of 9 24.3 $ Diagnostics & Research Sells AI Healthcare 183.10 $ +28.1 % +50.2 % +220.2 % −2.0 % +12.0 % 92 42 5.3 % 5.7 % 1.58 0.0 20.5 72.3 -5.4 -40.2 % 65.0 % -38.3 % -4,584.5 % -18.1 % -6.60 -9.5 % +32.9 % 3 0.0 % 0.0 % 0.1 106.0 % 8.6 % 4.7 (23)
ALGM Allegro Microsystems Inc 07/30 +12 % 66 % Stage 2 B 67 5 of 9 6.8 $ Semiconductors Sells AI Technology 33.10 $ +110.5 % +146.3 % +7.7 % −2.5 % +65.6 % 92 15 9.2 % 8.1 % 1.91 33.9 7.2 5.8 77.8 62.8 10.4 % 47.4 % 1.5 % -1.6 % 3.0 % 0.30 67.5 % +22.8 % 5 0.0 % 0.0 % 7.0 76.2 % 13.0 % 4.6 (11)
IESC IES Holdings Inc 08/07 +416 % 75 % Stage 2 A 78 6 of 9 6.7 $ Engineering & Construction Neutral Industrials 317.20 $ +82.6 % +77.9 % +77.3 % −4.7 % +38.7 % 92 79 7.0 % 6.3 % 1.78 15.7 208.3 1.7 5.5 19.1 18.9 11.5 % 26.3 % 11.4 % 42.1 % 16.5 % 0.11 53.8 % +16.9 % 7 0.0 % 0.0 % 9.3 96.9 % 9.0 %
POWI Power Integrations Inc 08/05 -1 % 63 % Stage 2 B 58 5 of 9 3.0 $ Semiconductors Technology 49.20 $ +128.3 % +114.0 % +12.2 % −7.0 % +57.5 % 92 12 6.6 % 7.2 % 1.53 152.4 23.4 6.6 3.8 37.6 1.51 51.0 7.4 % 53.7 % 5.6 % 2.4 % 2.6 % 87.2 % +5.9 % 5 1.8 % 115.5 % 16.7 116.1 % 14.4 % 4.6 (5)
EXTR Extreme Networks Inc 08/05 +12 % 55 % Stage 2 B 72 8 of 9 3.0 $ Communication Equipment Sells AI Technology 22.30 $ +88.9 % +90.5 % +0.2 % −4.1 % +50.2 % 92 90 4.3 % 5.0 % 1.76 187.2 16.2 2.3 37.2 22.9 0.81 33.9 5.5 % 61.5 % 3.3 % 21.6 % 3.4 % -0.74 6.8 % +2.1 % 5 0.0 % 0.0 % 0.7 100.8 % 9.1 % 4.0 (7)
KN Knowles Corporation 07/23 +45 % 40 % Stage 2 B 61 7 of 9 3.2 $ Electronic Components Technology 35.40 $ +87.1 % +85.2 % +59.6 % −5.0 % +23.6 % 92 61 4.9 % 4.6 % 1.60 49.1 15.2 5.3 3.8 44.2 0.43 23.0 11.8 % 45.3 % 10.6 % 8.2 % 5.5 % 0.19 74.0 % +7.2 % 5 0.0 % 0.0 % 6.3 103.9 % 7.2 % 4.3 (4)
MRX Marex Group plc 08/12 47 % Stage 2 B 62 4 of 9 5.2 $ Capital Markets Financial Services 73.30 $ +74.6 % +49.3 % +121.7 % −4.8 % +9.0 % 92 79 4.9 % 4.7 % -0.08 16.8 8.8 1.0 3.9 5.5 13.1 % 70.1 % 12.2 % 29.1 % 1.1 % 3.7 % +25.4 % 8 0.9 % 11.9 % 4.2 75.2 % 3.8 % 4.3 (8)
IMVT Immunovant Inc 08/10 -1 % 56 % Stage 2 D 30 2 of 9 7.8 $ Biotechnology Healthcare 37.70 $ +48.0 % +43.3 % +149.2 % −2.7 % +29.6 % 92 42 4.2 % 5.8 % 0.81 0.0 9.2 -14.1 0.0 % 0.0 % -64.8 % -46.7 % 0.00 89.1 % 3 0.0 % 0.0 % 8.1 54.7 % 17.0 % 4.6 (14)
ROG Rogers Corporation 07/30 +0 % 42 % Stage 2 B 56 9 of 9 2.4 $ Electronic Components Technology 130.90 $ +73.8 % +75.1 % +59.9 % −1.1 % +32.4 % 92 24 5.1 % 5.0 % 0.50 6.5 3.0 1.8 24.4 0.77 18.8 8.3 % 32.4 % 3.8 % -4.5 % 3.2 % 0.02 83.6 % -2.3 % 3 0.0 % 0.0 % 13.2 102.2 % 4.5 % 4.3 (3)
PACS PACS Group, Inc. 83 % Stage 2 B 72 7 of 9 6.5 $ Medical Care Facilities Healthcare 42.10 $ -2.7 % +7.0 % +274.9 % −5.6 % +40.1 % 92 90 4.8 % 4.7 % -0.13 15.9 1.2 19.3 1.06 20.3 8.5 % 17.3 % 4.9 % 27.1 % 4.6 % 18.3 % +29.3 % 5 0.0 % 0.0 % 4.2 30.5 % 6.9 % 4.8 (4)
NAT Nordic American Tankers Limited +50 % 39 % Stage 2 B 67 4 of 9 1.7 $ Oil & Gas Midstream Neutral Energy 8.20 $ +185.0 % −0.7 % -20.7 % 92 97 5.9 % 4.4 % -0.52 30.1 14.0 5.2 3.6 1.21 12.2 49.5 % 53.2 % 33.3 % 11.4 % 7.2 % 0.95 49.4 % -16.4 % 3 13.8 % 1.7 % 2.5 56.7 % 8.1 % 3.7 (3)
ETON Eton Pharmaceuticals Inc 08/06 +249 % 66 % Stage 2 B 64 7 of 9 1.6 $ Drug Manufacturers - Specialty & Generic Healthcare 57.10 $ +98.0 % +116.2 % +222.8 % −2.4 % +24.3 % 92 26 4.8 % 5.7 % 0.90 23.6 14.9 52.2 106.9 75.5 61.4 % 12.0 % -5.4 % 11.9 % 0.40 +104.9 % 8 0.0 % 0.0 % 0.7 65.4 % 6.5 % 4.7 (3)
RAPP Rapport Therapeutics, Inc. 08/06 56 % Stage 2 D 29 4 of 9 2.0 $ Biotechnology Healthcare 42.00 $ +28.1 % +30.6 % +59.5 % −8.0 % +47.7 % 92 42 6.0 % 6.1 % 1.03 0.0 98.9 4.4 0.0 -109.4 % 0.0 % -28.3 % -25.8 % 0.02 2 0.0 % 0.0 % 25.1 109.6 % 7.4 % 4.8 (5)
BCAX Bicara Therapeutics Inc. 08/11 61 % Stage 2 D 29 1 of 9 1.5 $ Biotechnology Healthcare 22.60 $ +48.5 % +69.9 % +105.9 % −5.8 % +52.8 % 92 42 6.8 % 5.8 % -0.82 0.0 2.9 0.0 0.0 % -32.3 % -26.1 % 0.00 4 0.0 % 0.0 % 18.5 104.3 % 22.8 % 4.4 (7)
LPRO Open Lending Corp 08/05 -23 % 77 % Stage 2 D 38 3 of 9 0.4 $ Credit Services Financial Services 3.10 $ +101.3 % +92.6 % +39.6 % −0.3 % -5.8 % 92 13 6.3 % 8.0 % 2.20 39.2 4.1 74.5 77.2 % -5.9 % -6.9 % 1.1 % +288.0 % 5 0.0 % 0.0 % 3.9 72.9 % 2.0 % 3.8 (8)
ULCC Frontier Group Holdings Inc 08/04 -7 % 76 % Stage 2 D 43 3 of 9 1.3 $ Airlines Industrials 5.90 $ +53.9 % +55.0 % +8.5 % −4.1 % +11.1 % 92 52 7.3 % 7.6 % 2.57 11.2 0.4 5.7 100.0 0.5 % -9.3 % -92.4 % -5.3 % 23.64 -1.4 % 4 0.0 % 0.0 % 1.7 55.2 % 42.2 % 3.0 (12)
CADL Candel Therapeutics Inc 08/13 +23 % 72 % Stage 2 D 35 3 of 9 0.8 $ Biotechnology Healthcare 11.30 $ +60.7 % +70.4 % +134.3 % −1.5 % +85.8 % 92 42 6.6 % 7.0 % -0.47 43.5 5.7 0.0 -74,432.3 % 0.0 % -51.2 % -28.6 % 0.01 -100.0 % 3 0.0 % 0.0 % 6.2 59.8 % 20.6 % 5.0 (3)
IMUX Immunic Inc 08/06 +0 % 80 % Stage 2 D 42 5 of 9 0.1 $ Biotechnology Healthcare 10.40 $ +182.2 % +163.9 % +24.7 % −4.4 % +326.6 % 92 42 6.7 % 8.8 % 1.41 0.0 0.2 0.0 % -142.9 % -66.8 % -100.0 % 0.0 % 0.0 % -2.1 46.9 % 11.6 % 4.7 (7)
ENTG Entegris Inc 07/29 +21 % 68 % Stage 2 B 63 7 of 9 22.4 $ Semiconductor Equipment & Materials Technology 134.70 $ +100.0 % +100.4 % +41.1 % −5.7 % +33.2 % 91 76 9.4 % 7.7 % 1.36 69.9 27.0 6.7 4.5 39.0 1.12 25.9 18.0 % 45.6 % 9.2 % 6.8 % 4.1 % 36.98 47.8 % -1.4 % 6 0.3 % 12.5 % 6.2 112.3 % 6.6 % 4.4 (9)
AEIS Advanced Energy Industries Inc 08/04 +84 % 63 % Stage 2 B 72 5 of 9 10.8 $ Electrical Equipment & Parts Industrials 254.40 $ +74.4 % +60.4 % +61.5 % −5.6 % +70.1 % 91 88 6.1 % 6.3 % 1.30 50.1 17.9 5.3 7.0 124.9 2.77 31.6 14.3 % 40.0 % 10.8 % 14.7 % 6.3 % 0.63 53.4 % +21.4 % 5 0.2 % 5.0 % 8.0 111.3 % 6.0 % 4.2 (11)
ROIV Roivant Sciences Ltd 08/10 +76 % 44 % Stage 2 D 39 3 of 9 28.0 $ Biotechnology Uses AI Healthcare 40.00 $ +48.4 % +54.4 % +161.7 % −1.9 % +18.3 % 91 2 3.9 % 4.0 % 1.12 0.0 3,730.8 6.2 0.7 -14,675.1 % -9,610.9 % 0.0 % -7.6 % -16.5 % 0.02 79.0 % -71.6 % 5 0.0 % 0.0 % 19.2 75.9 % 6.1 % 4.5 (10)
ARW Arrow Electronics Inc 07/30 +22 % 37 % Stage 2 B 68 7 of 9 11.5 $ Electronics & Computer Distribution Sells AI Technology 215.00 $ +104.6 % +91.0 % +80.6 % −3.5 % +11.0 % 91 90 3.3 % 3.6 % 1.19 14.3 5.0 0.3 1.5 12.7 0.95 9.4 4.2 % 11.3 % 2.3 % 11.3 % 2.7 % 0.53 18.8 % +10.5 % 2 0.0 % 0.0 % 5.5 108.6 % 3.4 % 2.7 (6)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Relative strength rating ≥ 90 and no more than 8% below the 52-week high — leading stocks at or near new highs.

All scanners are recalculated daily across the entire stock universe — most recently on September 18, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 132 stocks pass this scanner's criteria (as of September 18, 2026). The 100 strongest hits are shown.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?